Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats
Authors: Glazova NY, Manchenko DM, Volodina MA, Merchieva SA, Andreeva LA, et al.
A 2021 review of how Semax — a synthetic ACTH(4-10) analogue — dampens behavioural and neurochemical stress responses in the brain. Covers its effects on BDNF, serotonin and dopamine systems, and why Russian researchers study it for cognitive and stroke recovery.
Abstract
Selective serotonin reuptake inhibitors (SSRI) are commonly used to treat depression during pregnancy.. SSRIs cross the placenta and may influence the maturation of the foetal brain.. Clinical and preclinical findings suggest long-term consequences of SSRI perinatal exposure for the offspring.
Key Findings
Clinical and preclinical findings suggest long-term consequences of SSRI perinatal exposure for the offspring. | The mechanisms of SSRI effects on developing brain remain largely unknown and there are no directional approaches for prevention of the consequences of maternal SSRI treatment during pregnancy. | The aim of the present study was to investigate the long-term effects of neonatal exposure to the SSRI fluvoxamine (FA) in white rStudy Design
Animal studyMore Understanding Semax Peptide: Uses, Benefits & Safety Research Papers
Additional peer-reviewed studies and clinical trials indexed for Understanding Semax Peptide: Uses, Benefits & Safety on PepsReview:
- Semax, an ACTH4-10 peptide analog with high affinity for copper(II) ion and protective ability against metal induced cell toxicity — J Inorg Biochem, 2015 (220 citations)
Related Nootropic / Cognitive
Other peptides in the nootropic / cognitive category with research data available on PepsReview:
About This Understanding Semax Peptide: Uses, Benefits & Safety Research Paper
This study is part of PepsReview's indexed research library for Understanding Semax Peptide: Uses, Benefits & Safety. We systematically index peer-reviewed publications, clinical trial results, and scientific studies related to Understanding Semax Peptide: Uses, Benefits & Safety to provide researchers and clinicians with a centralized, searchable database of evidence. Each paper in our index includes metadata such as journal name, publication year, citation count, study type, and condition studied, along with key findings and study design summaries where available.
Understanding Semax Peptide: Uses, Benefits & Safety is classified in our Nootropic / Cognitive category. Discover what Semax peptide is: a neuroactive compound studied for brain signaling and recovery, not just a nootropic. Learn about its uses, potential benefits, side effects, and the importance of medical guidance. For a complete list of research papers on Understanding Semax Peptide: Uses, Benefits & Safety, visit the research index page. To compare vendor pricing and read user reviews, visit the main Understanding Semax Peptide: Uses, Benefits & Safety profile page.
Understanding Understanding Semax Peptide: Uses, Benefits & Safety Research
Understanding Semax Peptide: Uses, Benefits & Safety has been the subject of growing scientific interest, with researchers investigating its pharmacological properties, therapeutic potential, and safety profile across multiple study designs. The research landscape for Understanding Semax Peptide: Uses, Benefits & Safety includes preclinical in vitro and animal model studies that elucidate its mechanism of action, Phase I clinical trials assessing safety and pharmacokinetics in human subjects, and larger Phase II and Phase III trials evaluating efficacy in target populations. Published studies vary in design — some are randomized controlled trials with placebo groups, others are open-label dose-escalation studies, and many are retrospective analyses of real-world data from clinics and compounding pharmacies.
When interpreting Understanding Semax Peptide: Uses, Benefits & Safety research, it is important to consider several factors: the study population size and demographics, the dosage range tested, the duration of follow-up, the presence of confounding variables, and whether the results have been replicated in independent cohorts. Single studies, even well-designed ones, should not be considered definitive evidence. The strongest conclusions come from meta-analyses that pool data across multiple studies and from replicated findings across different research groups. Our research index for Understanding Semax Peptide: Uses, Benefits & Safety allows you to browse all available studies in one place and compare their methodologies, outcomes, and limitations side by side.
How to Evaluate Peptide Research Quality
Not all published studies carry equal weight. When reviewing Understanding Semax Peptide: Uses, Benefits & Safety research, consider the following quality indicators: peer-reviewed publication in a reputable journal with an impact factor, large sample sizes (n > 100 for clinical studies), randomized and blinded study designs, clearly defined endpoints, appropriate control groups, and disclosure of funding sources and potential conflicts of interest. Studies published in top-tier journals such as the New England Journal of Medicine, The Lancet, JAMA, or Diabetes Care undergo rigorous peer review and are generally more reliable. Preclinical studies and animal models, while valuable for hypothesis generation, should not be extrapolated to human use without clinical validation.
Additionally, pay attention to the condition studied and whether it aligns with your research interest. A study examining Understanding Semax Peptide: Uses, Benefits & Safety for one condition may not be applicable to a different therapeutic context. Dosage ranges, administration routes, and treatment durations can significantly affect outcomes. Always cross-reference findings with the broader literature and consult the full text of the original publication rather than relying solely on abstracts or summaries.
Related Research on Understanding Semax Peptide: Uses, Benefits & Safety
PepsReview continues to index new Understanding Semax Peptide: Uses, Benefits & Safety publications as they appear in the scientific literature. Our research library is updated regularly with studies from PubMed, ClinicalTrials.gov, and direct journal submissions. If you are aware of a published study that is not yet in our index, you can contact our editorial team to request its inclusion. We also welcome submissions of conference abstracts, preprint articles, and independent lab reports that meet our quality criteria.
For researchers new to Understanding Semax Peptide: Uses, Benefits & Safety, we recommend starting with the most highly cited papers in our index, as these typically represent foundational studies that have shaped the field. You can also browse by study type — clinical trials, animal studies, review articles, or case reports — to find the evidence most relevant to your work.
Research Disclaimer
The studies indexed on PepsReview are provided for educational and informational purposes only. They do not constitute medical advice. Peptides discussed in these publications may be investigational, and their safety and efficacy have not been established by the FDA unless explicitly noted. Always consult a qualified healthcare professional before making decisions based on research findings. PepsReview does not endorse, recommend, or guarantee the accuracy of any individual study. Our role is to index and organize published research for the convenience of the scientific community.